tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ORIC Stock Latest News

Is ORIC a Buy, Before Earnings?
Pre-EarningsIs ORIC a Buy, Before Earnings?
2d ago
ORIC
Promising Preclinical Data and Strategic Combinations Bolster Buy Rating for ORIC-944
PremiumRatings
Promising Preclinical Data and Strategic Combinations Bolster Buy Rating for ORIC-944
13d ago
ORIC
Oric Pharmaceuticals’ Promising Study on ORIC-944 for Metastatic Prostate Cancer
PremiumCompany Announcements
Oric Pharmaceuticals’ Promising Study on ORIC-944 for Metastatic Prostate Cancer
13d ago
ORIC
Oric Pharmaceuticals’ Promising Study on ORIC-114 for Solid Tumors
PremiumCompany Announcements
Oric Pharmaceuticals’ Promising Study on ORIC-114 for Solid Tumors
13d ago
ORIC
Oric Pharmaceuticals Advances in NSCLC Treatment with Phase 1b Study
PremiumCompany Announcements
Oric Pharmaceuticals Advances in NSCLC Treatment with Phase 1b Study
14d ago
ORIC
Oric Pharmaceuticals presents posters at EORTC-NCI-AACR on ORIC-944
PremiumThe FlyOric Pharmaceuticals presents posters at EORTC-NCI-AACR on ORIC-944
14d ago
ORIC
Promising Outlook for Oric Pharmaceuticals: Buy Rating Backed by Prostate Cancer Program Developments and Strong Financial Position
Premium
Ratings
Promising Outlook for Oric Pharmaceuticals: Buy Rating Backed by Prostate Cancer Program Developments and Strong Financial Position
21d ago
ORIC
ORIC Pharmaceuticals: Promising Oncology Developments and Strategic Trials Support Buy Rating
Premium
Ratings
ORIC Pharmaceuticals: Promising Oncology Developments and Strategic Trials Support Buy Rating
24d ago
ORIC
Oric Pharmaceuticals management to meet virtually with Cantor Fitzgerald
PremiumThe Fly
Oric Pharmaceuticals management to meet virtually with Cantor Fitzgerald
2M ago
ORIC
Oric Pharmaceuticals management to meet virtually with Cantor Fitzgerald
PremiumThe Fly
Oric Pharmaceuticals management to meet virtually with Cantor Fitzgerald
2M ago
ORIC
Oric Pharmaceuticals assumed with a Buy at Guggenheim
PremiumThe Fly
Oric Pharmaceuticals assumed with a Buy at Guggenheim
2M ago
ORIC
Oric Pharmaceuticals’ ORIC-944: A Promising PRC2 Inhibitor with Strategic Partnerships and Market Potential
PremiumRatings
Oric Pharmaceuticals’ ORIC-944: A Promising PRC2 Inhibitor with Strategic Partnerships and Market Potential
2M ago
ORIC
ORIC Pharmaceuticals Reports Q2 2025 Financial Results
PremiumCompany AnnouncementsORIC Pharmaceuticals Reports Q2 2025 Financial Results
3M ago
ORIC
Oric Pharmaceuticals appoints Kevin Brodbeck CTO
Premium
The Fly
Oric Pharmaceuticals appoints Kevin Brodbeck CTO
3M ago
ORIC
Oric Pharmaceuticals: Promising Future with Key Trials and Financial Stability Underpinning Buy Rating
Premium
Ratings
Oric Pharmaceuticals: Promising Future with Key Trials and Financial Stability Underpinning Buy Rating
3M ago
ORIC
Oric Pharmaceuticals price target lowered to $19 from $22 at H.C. Wainwright
PremiumThe Fly
Oric Pharmaceuticals price target lowered to $19 from $22 at H.C. Wainwright
3M ago
ORIC
Oric Pharmaceuticals Faces Potential Setbacks Amid Competitors’ Clinical Trials
PremiumCompany Announcements
Oric Pharmaceuticals Faces Potential Setbacks Amid Competitors’ Clinical Trials
3M ago
ORIC
Oric Pharmaceuticals Focuses on Lead Clinical Programs
PremiumCompany Announcements
Oric Pharmaceuticals Focuses on Lead Clinical Programs
3M ago
8K
ORIC
Oric Pharmaceuticals reports Q2 EPS (47c), consensus (44c)
PremiumThe Fly
Oric Pharmaceuticals reports Q2 EPS (47c), consensus (44c)
3M ago
ORIC
Oric Pharmaceuticals initiated with a Buy at Ladenburg
PremiumThe FlyOric Pharmaceuticals initiated with a Buy at Ladenburg
4M ago
ORIC
Oric Pharmaceuticals Elects Directors at Annual Meeting
Premium
Company Announcements
Oric Pharmaceuticals Elects Directors at Annual Meeting
5M ago
8K
ORIC
JPMorgan biotech/pharma analysts hold analyst/industry conference call
Premium
The Fly
JPMorgan biotech/pharma analysts hold analyst/industry conference call
5M ago
JNJ
PFE

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >